ipriflavone has been researched along with Hypergonadotropic Hypogonadism in 2 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gambacciani, M | 1 |
Cappagli, B | 1 |
Piaggesi, L | 1 |
Ciaponi, M | 1 |
Genazzani, AR | 1 |
Ohishi, T | 1 |
Koide, Y | 1 |
Takahashi, M | 1 |
Oikawa, M | 1 |
Kushida, K | 1 |
1 trial available for ipriflavone and Hypergonadotropic Hypogonadism
Article | Year |
---|---|
Ipriflavone prevents the loss of bone mass in pharmacological menopause induced by GnRH-agonists.
Topics: Absorptiometry, Photon; Analysis of Variance; Antineoplastic Agents, Hormonal; Bone Density; Bone Re | 1997 |
1 other study available for ipriflavone and Hypergonadotropic Hypogonadism
Article | Year |
---|---|
A case of femoral neck fracture in a patient with severe testosterone deficiency.
Topics: Aged; Bone Density; Calcitonin; Femoral Neck Fractures; Humans; Hydroxycholecalciferols; Hypogonadis | 1999 |